Nureca Share Price

Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the Companies Act, 2013. The Company got converted to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. Nureca is a digitally native, consumer healthcare company with a leading presence in categories such as home diagnostics, wellness devices, and personal fitness equipment under brands like Dr Trust and Dr Physio. The Company's differentiated strategy is built around four pillars: Product Innovation, Omnichannel Distribution, Direct-to-Consumer (D2C) Excellence and In-House Manufacturing Capabilities. The Company is engaged in the business of home healthcare and wellness products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives. In 2017, the Company commenced business operations and launched 'Dr. Trust' brand through digital healthcare channel. In 2018, the Company widened product basket with launching of brands in electric massages and mother & child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh. In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Company's key products secured a warehouse drug license. In 2019, the Company took the effect of demerger, whereby certain portion of business activities of Nectar Biopharma Private Limited was transferred to the Company, making the Scheme effective from May 23, 2020. The Company came up with IPO of 25,01,315 equity shares of Rs 10 each and raised funds through fresh issue of Rs 100 crore on February 17, 2021.